News
VISU academy 3rd June, 1-2pm with Dr Koopowitz
Unlock your dispensary’s full potential at Dispex Live
It’s now less than 2 months before Dispex hits the road and meets delegates face-to-face at the Cambridge Belfry Hotel, CB23 6BW. We chose this venue as it covers a...
How to Access Dispex’s Guide to Understanding your PCSE Drug Statement
Exclusive Members’ Resource Keeping a watchful eye on your PCSE drug statements and prescription charges has always been an important aspect of best practice. However, in light of the present...
What Are Dispex Members Talking About- April?
April The Dispex WhatsApp group isn’t just expert-led; it’s powered by real-world experience from members facing the same challenges every day. In recent discussions, members quickly stepped in to support...
Keeping an eye on Glaucoma Eye Drops
By Dr Philip Koopowitz – Director Dispex When looking at the options available for dispensaries, it can become confusing as trying to compare like for like is very difficult. Click...
Don’t miss out on this valuable resource- Dispex SOPs
Dispex members have exclusive access to our comprehensive SOPs library. Designed to streamline operations and ensure compliance. Don’t miss out on this valuable resource—join today and elevate your dispensing procedures...
Class 4 Medicines Defect Notification: Milpharm Limited, Loperamide hydrochloride 2 mg Orodispersible Tablets, EL(26)A/23
Source: MHRA/Gov.uk 11.05.2026 Milpharm Limited has identified a discrepancy in the Patient Information Leaflet (PIL) approved for Loperamide hydrochloride 2 mg Orodispersible Tablets. DMRC reference number DMRC – 39394163 Marketing...
Class 2 Medicines Recall: Amarox Limited, Sertraline 100mg film-coated tablets, EL(26)A/22
Source: MHRA/Gov.uk 28.04.2026 Amarox Limited is recalling one batch of Sertraline 100 mg film-coated tablets as a precautionary measure due to an error at the manufacturing site. DMRC reference number...
Dispensary Profitability Review
Our consultant will typically spend about 2 hours in the dispensary, observing and asking questions. He will look at processes and potential efficiencies. Our consultant will then spend some time...
Class 3 Medicines Recall: Omega Pharma Ltd, Napralief 250mg Gastro-Resistant Tablets, EL(26)A/21
Source: MHRA/Gov.uk 24.04.2026 Amended from 23.04.2026 Omega Pharma Ltd is recalling specific batches of Napralief 250mg Gastro-Resistant Tablets due to missing text in Section 2 and Section 3 of the...
Class 3 Medicines Recall: Omega Pharma Ltd, Napralief 250mg Gastro-Resistant Tablets, EL(26)A/21
Source: MHRA/Gov.uk 23.04.2026 Omega Pharma Ltd is recalling specific batches of Napralief 250mg Gastro-Resistant Tablets due to missing text in Section 2 and Section 3 of the Patient Information Leaflet...
Class 4 Medicines Defect Notification: Doncaster Pharma Limited, Hiprex 1g tablets, EL(26)A/20
Source: MHRA/Gov.uk 22.04.2026 Doncaster Pharma Limited has informed the MHRA of an error related to the Braille embossing on the outer packaging of certain parallel imported batches of Hiprex 1...
